MAPT and Alzheimer disease: Recent studies have demonstrated that autophagy-related drugs or compounds, such as the mTOR inhibitor rapamycin, can rescue the cognitive deficits and remove the aggregates (such as Aβ and tau) in AD cases efficiently [74, 103].